Subject: Attention, your iPSC future starts here

 
Dear Colleague,

2024 is starting off with a bang in the iPSC community! With the emergence of 2 new iPSC-focused biotechs, Kenai Therapeutics and Shinobi Therapeutics, it's clear excitement is developing in stem cell therapeutics and more is still to come.

With support from BioInformant, we are thrilled to be re-uniting the entire iPSC community once again at the 4th iPSC Drug Development & Manufacturing Summit taking place in Boston, October 1-3.

Be the first to access the full session details and expert speaker faculty here.

After listening to our audience, for the first time in four years, we have combined our two annual iPSC meetings into one larger, singular touchpoint meeting. With novel insights and content for your entire team, our two tracked meeting will cover Research & Development through to Manufacturing & Analytical Development in the iPSC Space.
 
 

Uncovering new clinical data from trailblazing iPSC companies including Kenai Therapeutics, Aspen Neuroscience and NIST, don’t miss this golden opportunity to shape the future of your iPSC pipeline.

The esteemed speaker faculty who will share unmissable data includes:

  • *NEW* Kim Raineri, Chief Technology Officer, Aspen Neuroscience
  • Wei Li, Chief Scientific Officer, Cytovia Therapeutics
  • *NEW* Howard Federoff, Chief Medical Officer & Co-Founder, Kenai Therapeutics
  • Allen Feng, Founder & Chief Scientific Officer, HebeCell
  • Michael Naso, Senior Vice President, Cell Engineering, Century Therapeutics
  • *NEW* Joseph Wu, Professor & Director, Stanford Cardiovascular Institute
  • Anne Plant, Chief, Biosystems & Biomaterials Division, NIST
  • *NEW* Takehiko Kaneko, Head of R&D & Chief Medical Officer, Heartseed

Join these industry leaders and many more, as they discuss the most cutting-edge research in the iPSC community including approaches to enhance iPSC differentiation, integrating AI and automation and tackling new challenges like Parkinson’s Disease and solid tumors.

View the full session details now. 

Can you really afford to miss out? The best possible rates are still available, save up to $1,100 if you book by Friday June 14. This leaves you until this Friday to coordinate with your wider teams and organize your group booking (which could save you a further 20%).

With 3 days of networking, exclusive clinical presentations and strategic discussions, grab your team and secure your pass today to stand at the forefront of iPSC cell therapy revolution.

We look forward to seeing you in October!

Best wishes, 

Aidan 

Aidan Steele
Program Director – 4th iPSC Drug Development & Manufacturing Summit
Hanson Wade

Event Guide | Register | Contact Us
 
 
 

    This is an online snapshot of a newsletter created by the owner of BioInformant Worldwide, LLC | Stem Cell Industry Data (BioInformant.com, BIOINFORMANT | 800 Corporate Drive, Suite 301, 22554 Stafford) and sent via GetResponse on 2024-06-11. Report abuse